Clinical Trial Update: Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial comparing AGN-210961 ophthalmic solution with bimatoprost ophthalmic solution in patients with ocular hypertension or primary open-angle glaucoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AGN-210961
• Bimatoprost ophthalmic solution (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Ocular Hypertension, Primary Open-Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-05